株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

神経刺激装置の世界市場の将来予測

GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2017-2025

発行 Inkwood Research 商品コード 530650
出版日 ページ情報 英文 162 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
神経刺激装置の世界市場の将来予測 GLOBAL NEUROSTIMULATION DEVICE MARKET FORECAST 2017-2025
出版日: 2017年07月19日 ページ情報: 英文 162 Pages
概要

当レポートでは、世界の神経刺激装置市場の将来展望について分析し、市場の基本構造・背景構造や、主な促進・抑制要因や、市場全体および製品別・用途別・地域別の市場動向見通し (今後9年間分)、現在の市場求心力の水準と企業間競争の動向、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場の決定要因

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第5章 市場区分

  • 装置別の市場区分 (今後9年間分)
    • 脊髄刺激装置 (SCS)
    • 脳深部刺激装置 (DBS)
    • 仙骨神経刺激装置 (SNS)
    • 迷走神経刺激装置 (VNS)
    • その他
  • 用途別の市場区分 (今後9年間分)
    • 疼痛管理
    • てんかん
    • 本態性振戦
    • 尿失禁・便失禁
    • うつ病
    • 筋緊張異常
    • 胃不全麻痺
    • パーキンソン病

第6章 主要指標

  • ポーターのファイブフォース分析
  • 推計分析
    • 精神疾患の有病者数の増加
    • 世界各国での医療費の拡大
    • 高齢者人口の増加
  • バリューチェーン分析
    • 医薬品関連:メーカー・流通業者・小売店舗・エンドユーザー
    • 医療機器関連:メーカー・流通業者・エンドユーザー
  • 市場機会マトリックス
  • ベンダー環境

第7章 地域分析

  • 北米 (米国、カナダ)
  • 欧州 (英国、フランス、ドイツ、スペインなど)
  • アジア太平洋地域 (インド、中国、日本、オーストラリアなど)
  • 他の国々 (RoW)

第8章 企業プロファイル

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 6409

KEY FINDINGS

The global neurostimulation device market which was worth $1902 million in 2016 is anticipated to grow at a CAGR of 8.67% during the forecast period of 2017-2025. Its net worth is estimated to rise up to $4004 million by the end of 2025. The fact that these devices aid in the therapeutic activation for many neurological diseases is majorly driving the market. Other factors include the high occurrence of diseases, second-line of treatment, increased elderly populace and the various developments in technology.

MARKET INSIGHTS

The global neurostimulation device market can be segmented on the basis of the type of system and by the application type. The different type of systems can be classified as Global DBS system market, Global SCS system market, Global SNS system market, Global VNS system market and Others. The application of the neurostimulation devices can be seen in Depression market, Pain management market, Essential tremor market, Epilepsy market, Urinary and fecal incontinence market, Dystonia market, Gastroparesis market and in Parkinson's disease market. Albeit such wide range of applications, safety concerns remains to be one of the major market challenges. Patients might be at a risk of contracting infections at the time of implantation or may face issues if they are in contact with or near to electromagnetic radiation and electrical and gas-powered appliances. Also, the malfunction of the implanted device might go unnoticed by the patient leading to higher risks.

REGIONAL INSIGHTS

Geographically, the market can be divided into four major regions, which includes:

North America - U.S. & Canada

Asia-Pacific - China, India, Japan, Australia, Rest of APAC

Europe - UK, France, Germany, Spain, and Rest of Europe

Rest of World

The Asia-Pacific market is predicted to show the fastest growth over the forecast period. Factors like a large patient base and the rising investments in healthcare sectors in countries like China and Japan are proving conducive to the market growth in this region. At present, however, the North America region is leading the market scene. The United States is a major revenue contributor to the global neurostimulation device market. The North American region is expected to continue this dominance and hold the highest share by 2025 in the global market. The market is wildly attracting investors from all over the globe because of profitable aspects like advances in technology and the US government's increased focus on improving patient safety and procedure efficiency by using neurostimulation devices.

COMPETITIVE INSIGHTS

St. Jude Medical is a global medical device manufacturer that develops medical technology, products, and services for the treatment of neurological, chronic pain, and cardiac patients. Another company, Boston Scientific caters to high-quality medical devices used in the treatment of a large number of medical conditions. Medtronic Inc. manufactures and sells device-centered medicinal treatments globally along with assembling intra-operative imaging systems and image-guided surgery. It also offers web-based therapy management software solutions. The other major players in the market include Aleva Neurotherapeutics SA, Cogentix Medical Inc, Depuy Synthes Companies, Dr. Langer Medical GMBH, EBS Technologies Gmbh, Intrapace Inc, Neurological Surgery PC, Neuronetics Inc, Nevro Corp, and the Magstim Company Limited.

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NEUROSTIMULATION DEVICE MARKET IS GROWING AT A MODERATE RATE
    • 3.2.2. UNITED STATES IS THE MAJOR REVENUE CONTRIBUTOR
    • 3.2.3. AID IN THE THERAPEUTIC ACTIVATE

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. HIGH OCCURRENCE OF DISEASES
    • 4.1.2. DEVELOPMENTS IN TECHNOLOGY
    • 4.1.3. INCREASED POPULACE OF ELDERLY PEOPLE
    • 4.1.4. SECOND-LINE OF TREATMENT
  • 4.2. RESTRAINTS
    • 4.2.1. HIGH VALUE OF SCS DEVICE AND EARLY TREATMENT
    • 4.2.2. POSSIBLE SIDE EFFECTS OF SCS THERAPY AND COMPLICATIONS
    • 4.2.3. ANONYMOUS APPLIANCE OF SCS THERAPY
  • 4.3. OPPORTUNITIES
    • 4.3.1. DEVELOPMENT OF INDICATION FOR SCS
    • 4.3.2. REQUIREMENT FOR MRI DEVICES
    • 4.3.3. GROWING OCCURRENCE OF CHRONIC DISCOMFORT
  • 4.4. MARKET CHALLENGES
    • 4.4.1. OBTAINABILITY OF ALTERNATIVE THERAPY
    • 4.4.2. HIGH PRICE OF TREATMENT
    • 4.4.3. SAFETY CONCERNS

5. MARKET SEGMENTATION

  • 5.1. MARKET BY SYSTEM 2017-2025
    • 5.1.1. GLOBAL SCS SYSTEM MARKET
    • 5.1.2. GLOBAL DBS SYSTEM MARKET
    • 5.1.3. GLOBAL SNS SYSTEM MARKET
    • 5.1.4. GLOBAL VNS SYSTEM MARKET
    • 5.1.5. OTHERS
  • 5.2. MARKET BY APPLICATION 2017-2025
    • 5.2.1. PAIN MANAGEMENT MARKET
    • 5.2.2. EPILEPSY MARKET
    • 5.2.3. ESSENTIAL TREMOR MARKET
    • 5.2.4. URINARY AND FECAL INCONTINENCE MARKET
    • 5.2.5. DEPRESSION MARKET
    • 5.2.6. DYSTONIA MARKET
    • 5.2.7. GASTROPARESIS MARKET
    • 5.2.8. PARKINSON'S DISEASE MARKET

6. KEY ANALYTICS

  • 6.1. PORTERS 5 FORCES ANALYSIS
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTES
    • 6.1.3. BARGAINING POWER OF SUPPLIERS
    • 6.1.4. BARGAINING POWER OF BUYERS
    • 6.1.5. THREAT OF RIVALRY
  • 6.2. ESTIMATION ANALYSIS
    • 6.2.1. INCREASING PREVALENCE OF MENTAL HEALTH PROBLEME
    • 6.2.2. RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
    • 6.2.3. RISING GERIATRIC POPULATION
  • 6.3. VALUE CHAIN ANALYSIS
    • 6.3.1. FOR DRUGS
      • 6.3.1.1. MANUFACTURERS
      • 6.3.1.2. DISTRIBUTORS
      • 6.3.1.3. RETAILERS
      • 6.3.1.4. END-USERS
    • 6.3.2. FOR DEVICES
      • 6.3.2.1. MANUFACTURERS
      • 6.3.2.2. DISTRIBUTORS
      • 6.3.2.3. END-USERS
  • 6.4. OPPORTUNITY MATRIX
  • 6.5. VENDOR LANDSCAPE

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. SPAIN
    • 7.2.5. REST OF EUROP
  • 7.3. ASIA-PACIFIC
    • 7.3.1. INDIA
    • 7.3.2. CHINA
    • 7.3.3. JAPAN
    • 7.3.4. AUSTRALIA
    • 7.3.5. REST OF APAC
  • 7.4. REST OF WORLD

8. COMPANY PROFILES

  • 8.1. ALEVA NEUROTHERAPEUTICS SA
  • 8.2. BOSTON SCIENTIFIC CORPORATION
  • 8.3. COGENTIX MEDICAL INC
  • 8.4. CYBERONICS INC
  • 8.5. DEPUY SYNTHES COMPANIES
  • 8.6. DR. LANGER MEDICAL GMBH
  • 8.7. EBS TECHNOLOGIES GMBH
  • 8.8. INTRAPACE INC
  • 8.9. MEDTRONIC PLC
  • 8.10. NEUROLOGICAL SURGERY PC
  • 8.11. NEURONETICS INC
  • 8.12. NEVRO CORP.
  • 8.13. ST. JUDE MEDICAL, INC.
  • 8.14. THE MAGSTIM COMPANY LIMITED

TABLE LIST

  • TABLE # 1 GLOBAL NEUROSTIMULATION MARKET BY REGION 2017-2025($ MILLION)
  • TABLE # 2 GLOBAL SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • TABLE # 3 GLOBAL NEUROSTIMULATION MARKET, BY APPLICATION 2017-2025 ($ MILLIONS)
  • TABLE # 4 GLOBAL NEUTRACEUTICAL DEVICE MARKET, BY REGION 2017-2025 ($ MILLION)
  • TABLE # 5 CONDITION TREATED BY NEUROSTIMULATION DEVICES IN US
  • TABLE # 6 NORTH AMERICA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • TABLE # 7 EUROPE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • TABLE # 8 ASIA PACIFIC NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE LIST
  • FIGURE # 1 GLOBAL NEUROSTIMULATION MARKET 2017-2025($ MILLION)
  • FIGURE # 2 GLOBAL SCS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 3 GLOBAL DBS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 4 GLOBAL SNS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 5 GLOBAL VNS SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 6 GLOBAL OTHER SYSTEM MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 7 GLOBAL PAIN MANAGEMENT MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 8 GLOBAL EPILEPSY MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 9 GLOBAL ESSENTIAL TREMOR MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 10 GLOBAL URINARY AND FECAL INCONTINENCE MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 11 GLOBAL DEPRESSION MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 12 GLOBAL DYSTONIA MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 13 GLOBAL GASTROPARESIS MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 14 GLOBAL PARKINSON'S DISEASE MARKET 2017-2025 ($ MILLIONS)
  • FIGURE # 15 PREVALENCE OF MENTAL HEALTH DISORDERS ACROSS THE GLOBE BETWEEN PERIOD 2012 AND 2020 (MILLION)
  • FIGURE # 16 RISING GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)
  • FIGURE # 17 VALUE CHAIN OF ANTIDEPRESSANT DRUGS
  • FIGURE # 18 UNITED STATES NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 19 CANADA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 20 UNITED KINGDOM NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 21 FRANCE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 22 GERMANY NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 23 SPAIN NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 24 REST OF EUROPE NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 25 INDIA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 26 CHINA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 27 JAPAN NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 28 AUSTRALIA NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 29 REST OF APAC NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
  • FIGURE # 30 REST OFWORLD NEUTRACEUTICAL DEVICE MARKET 2017-2025 ($ MILLION)
Back to Top